A Key Step Forward in the Medical Devices Market
Choosing Complife means choosing a partner that can accompany your MD product in all its life cycle: from the first phases of pre-market analysis until the maintenance in the market.
Complife group, in fact, starting from February 2024 can offer a fully comprehensive service for its customers in the MD market, positioning itself as a Unique Reference to support its customers at every step of the product development process.
Thanks to the synergy between all the companies that are part of the group, today we can share a very complete offer.
WHAT ARE OUR SERVICES:
Starting from organizational consulting, Complife team will define an ad hoc BUSINESS STRATEGY and attend to all the stages of evolution of the MEDICAL DEVICE, up to the definition of the correct positioning in the reference market and the maintenance of a successful presence.
WHAT ARE OUR STRENGHTS:
Unique Reference
Thanks to the synergies of the group and our highly qualified network, we can be the only reference service provider for the verification of product compliance in all phases of the medical device life cycle and thus satisfy every customer request.
Specialization
We operate in the medical sector (medical devices, in vitro diagnostic medical devices and combination products) with highly specialized workforce and resources, exactly as required by the market. Through our technologically advanced laboratories, innovative procedures and continuous specific training we provide a service of the highest professionalism and technical level.
Global Expertise
The up-to-date knowledge of international regulatory scenarios, together with the deployment of our offices, services and laboratories across multiple territories, allow us to support our customers in every market.
Complife group can be your unique partner in the Medical Devices Market, Feel free to ask for more information to tour team of experts.
TEAM OF EXPERTS
COMPLIFE. COMMITTED TO SCIENCE, COMMITTED TO YOU.
Share this article
Latest articles
December 18, 2024
December 18, 2024